RFK Jr.'s second Senate confirmation hearing focused on vaccines, Medicare, diversity, and science. Key Republicans were reticent to show support.
Shares of Vertex Pharmaceuticals rose after Journavx, the company's oral non-opioid pain medication, received Food and Drug Administration approval. The Boston company's stock rose 4.3%, to $457.25, ...
The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...
Kennedy will also have to win over the swing votes of Sens. Susan Collins, Lisa Murkowski and Mitch McConnell, who have ...
Kennedy Jr, President Donald Trump's pick to run the top U.S. health agency, argued on Thursday that his controversial views ...
Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...
While Mr. Kennedy, seeking the job of health secretary, has been vocal about vaccines and his desire to overhaul the nation’s ...
President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...